FDA
approval
· 2012-09-04
FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
FDA approved a supplemental application for labetalol hydrochloride (Hospira, Inc.), supporting the generic drug's availability.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)